Abstract
Oncology has undergone rapid progress, with emerging developments in areas including cancer stem cells, molecularly targeted therapies, genomic analyses, and individually tailored immunotherapy. These advances have expanded the tools available in the fight against cancer. Some of these have seen broad media coverage resulting in justified public attention. However, these achievements have only been possible due to rapid developments in the expanding field of biomedical informatics and information technology (IT). Artificial intelligence, radiomics, electronic health records, and electronic patient-reported outcome measures (ePROMS) are only a few of the developments enabling further progress in oncology. The promising impact of IT in oncology will only become reality through a multidisciplinary approach to the complex challenges ahead.
References
1.
Fenn
J
, Linden
A
. Understanding Gartner’s hype cycles. Strategic analysis report No. R-20-1971
. Gartner, Inc
; 2003
. p. 88
.2.
Basch
E
, Deal
AM
, Dueck
AC
, Scher
HI
, Kris
MG
, Hudis
C
, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment
. JAMA
. 2017 Jul 11
;318
(2
):197
–8
. 3.
Denis
F
, Lethrosne
C
, Pourel
N
, Molinier
O
, Pointreau
Y
, Domont
J
, et al. Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients
. J Natl Cancer Inst
. 2017 Sep 1
;109
(9
). 4.
Ahlbrandt
J
, Lablans
M
, Glocker
K
, Stahl-Toyota
S
, Maier-Hein
K
, Maier-Hein
L
, et al. Modern information technology for cancer research: What’s in IT for me? An overview of technologies and approaches
. Oncology
. 2018 Nov 15
. .5.
Dubovitskaya
A
, Novotny
P
, Xu
Z
, Wang
F
. Applications of blockchain technology for data-sharing in oncology: Results from a systematic literature review
. Oncology
. 2019 Dec
. .6.
Savova
GK
, Danciu
I
, Alamudun
F
, Miller
T
, Lin
C
, Bitterman
DS
, et al. Use of natural language processing to extract clinical cancer phenotypes from electronic medical records
. Cancer Res
. 2019
;79
(21
):5463
–70
.7.
Henkel
M
, Stieltjes
B
. Structured data acquisition in oncology
. Oncology
. 2019 Nov
..8.
Hewer
E
. The oncologist’s guide to synoptic reporting: A primer
. Oncology
. 2019 Jun
. .9.
Esteva
A
, Kuprel
B
, Novoa
RA
, Ko
J
, Swetter
SM
, Blau
HM
, et al. Corrigendum: Dermatologist-level classification of skin cancer with deep neural networks
. Nature
. 2017
;546
(7660
):686
–18
. 10.
Ardila
D
, Kiraly
AP
, Bharadwaj
S
, Choi
B
, Reicher
JJ
, Peng
L
, et al. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography
. Nat Med
. 2019
;25
(6
):954
–61
.11.
Shen
L
, Margolies
LR
, Rothstein
JH
, Fluder
E
, McBride
R
, Sieh
W
. Deep learning to improve breast cancer detection on screening mammography
. Sci Rep
. 2019
;9
(1
):12495
–12
.12.
El Naqa
I
, Haider
MA
, Giger
ML
, Ten Haken
RK
. Artificial Intelligence: reshaping the practice of radiological sciences in the 21st century
. Br J Radiol
. 2020 Feb
;93
(1106
):20190855
.13.
Lambin
P
, Leijenaar
RT
, Deist
TM
, Peerlings
J
, De Jong
EEC
, Van Timmeren
J
, et al. Radiomics: the bridge between medical imaging and personalized medicine
. Nat Rev Clin Oncol
. 2017 Dec
;14
(12
):749–762
.14.
Haibe-Kains
B
, Adam
GA
, Hosny
A
, Khodakarami
F
, Board
M
, Waldron
L
, et al. The importance of transparency and reproducibility in artificial intelligence research
. arXiv preprint. arXiv:2003.00898. 2020
.15.
Glatzer
M
, Panje
C
, Sirén
C
, Cihoric
N
, Putora
P
. Decision making criteria in oncology
. Oncology
. 2018 Sep
. .16.
Iseli
T
, Fischer
G
, Panje
C
, Glatzer
M
, Hundsberger
T
, Rothermundt
C
, et al. Insular decision criteria in clinical practice: Analysis of decision-making in oncology. Oncology.
2020
. https://doi.org/10.1159/000508132
.17.
Treffers
T
, Putora
P
. Emotions as social information in shared decision-making in oncology
. Oncology.
2020 Jan
. .18.
Giordano
F
, Welzel
G
, Siefert
V
, Jahnke
L
, Ganslandt
T
, Wenz
F
, et al. Digital follow-up and the perspective of patient-centered care in oncology: What’s the PROblem?
Oncology
. 2018 Dec
. .19.
El Shafie
RA
, Weber
D
, Bougatf
N
, Sprave
T
, Oetzel
D
, Huber
PE
, et al. Supportive care in radiotherapy based on a mobile app: Prospective multicenter survey
. JMIR Mhealth Uhealth
. 2018 Aug
;6
(8
):e10916
.20.
Kessel
KA
, Vogel
MM
, Alles
A
, Dobiasch
S
, Fischer
H
, Combs
SE
. Mobile app delivery of the EORTC QLQ-C30 questionnaire to assess health-related quality of life in oncological patients: usability study
. JMIR Mhealth Uhealth
. 2018 Feb
;6
(2
):e45
.21.
Pavic
M
, Klaas
V
, Theile
G
, Kraft
J
, Tröster
G
, Guckenberger
M
. Feasibility and usability aspects of continuous remote monitoring of health status in palliative cancer patients using wearables
. Oncology
. 2019 Jul
. .22.
Gupta
A
, Stewart
T
, Bhulani
N
, Dong
Y
, Rahimi
Z
, Crane
K
, et al. Feasibility of wearable physical activity monitors in patients with cancer
. JCO Clin Cancer Inform
. 2018 Dec
;2
:1
–10
.23.
Tseng
H
, Wei
L
, Cui
S
, Luo
Y
, Ten Haken
R
, El Naqa
I
. Machine learning and imaging informatics in oncology
. Oncology
. 2018 Nov
. .24.
Wortham
RH
, Theodorou
A
, Bryson
JJ
. Improving robot transparency: Real-time visualisation of robot AI substantially improves understanding in naive observers
. In: 2017 26th IEEE International Symposium on Robot and Human Interactive Communication (RO-MAN), Lisbon, 2017
. p. 1424
–31
.25.
Schlachter
M
, Preim
B
, Bühler
K
, Raidou
R
. Principles of visualization in radiation oncology
. Oncology.
2020 Jan
. .26.
Luo
Y
, Tseng
H-H
, Cui
S
, Wei
L
, Ten Haken
RK
, El Naqa
I
. Balancing accuracy and interpretability of machine learning approaches for radiation treatment outcomes modeling
. BJR Open
. 2019
;1
(1
):20190021
.© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
